Timing is everything. A new blood test acts as a biological "clock," predicting when Alzheimer's symptoms will begin years before they actually appear.

Published guidance for consumers also emphasises delays are based on test type, not the result, and do not indicate an adverse finding. The retained delay for most imaging is intended to allow the ...

The purpose of this survey was to combine qualitative and quantitative insights to understand the current oncology landscape.

MAPPM complaint states that laboratory test reports bear signature of a Pune-based pathologist who died on November 20, 2025 ...

Findings could streamline enrollment for Alzheimer's clinical trials ...

The Scottish Medicines Consortium has rejected donanemab for early Alzheimer’s disease, citing inadequate clinical and economic evidence.

These students, all juniors at the healthcare-focused Boston Public Schools high school, were preparing to take the state-certified nursing assistant exam in April.

Thousands of lawsuits in the U.S. allege that the agrochemical maker Bayer failed to warn people that its popular weedkiller ...

Software providers that won’t share data are creating unnecessary friction within the healthcare system and should be ...

Dark, diamond-shaped spots in inner ear magnetic resonance imaging (MRI) scans are not always signs of pathological ...

José María Suárez Feito introduces the OccluSense system for digital occlusion analysis and its uses in tooth wear cases.

Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope's strategic focus on early, actionable dementia detection. ROCKVILLE, ...